SP
Selvaraju Pandurangan
About Selvaraju Pandurangan
Data last updated:
Selvaraju Pandurangan is a Director at Sri Kauvery Medical Care (India) Limited (since 2023) and Director at Curtis Drug Point Private Limited (since 2017). The companies operate in Healthcare, Pharma and Real Estate and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹1,999 Cr; the largest is Sri Kauvery Medical Care (India) Limited at ₹1,918 Cr (FY 2025). Earlier, Selvaraju Pandurangan was a Director at Park Hill Estates Private Limited (2012–2016) and Director at Pda Holdings Private Limited (2015) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sri Kauvery Medical Care (India) Limited U85110TN1997PLC039491 | Director | 31 Aug 2023 | 1997 | ₹1,918 Cr (FY 2025) | Active |
 Curtis Drug Point Private Limited U74999TN2017PTC119150 | Director | 18 Oct 2017 | 2017 | ₹80.85 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Park Hill Estates Private Limited U45206TN2012PTC085961 | Director | 25 May 2012 | 2012 | ₹11.28 Cr (FY 2018) | Amalgamated |
| Pda Holdings Private Limited U85110TN2011PTC078784 | Director | 28 Jan 2015 | 2011 | Active | |
 Karaikudi Medical Centre And Hospital Limited U85191TN2014PLC094477 | Director | 12 Feb 2020 | 2014 | ₹27.25 Cr (FY 2024) | Active |
 Mediplus Healthcare Pharmacy India Private Limited U51397TN2008PTC066538 | Director | 20 Feb 2008 | 2008 | ₹9.45 Cr (FY 2017) | Active |
| Alliance Diagnostics Llp AAG-2923 | Designated Partner | 23 Mar 2020 | 2016 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Selvaraju Pandurangan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Selvaraju Pandurangan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Selvaraju Pandurangan
Selvaraju Pandurangan currently holds 2 directorships: Sri Kauvery Medical Care (India) Limited (Director, since 31 Aug 2023, revenue ₹1,918 Cr (FY 2025)); Curtis Drug Point Private Limited (Director, since 18 Oct 2017, revenue ₹80.85 Cr (FY 2025)).
Selvaraju Pandurangan was first appointed on 20 Feb 2008 as Director at Mediplus Healthcare Pharmacy India Private Limited. The most recent appointment on record is 31 Aug 2023 at Sri Kauvery Medical Care (India) Limited.
The 2 current companies of Selvaraju Pandurangan that report revenue have a combined latest revenue of ₹1,999 Cr: Sri Kauvery Medical Care (India) Limited ₹1,918 Cr (FY 2025); Curtis Drug Point Private Limited ₹80.85 Cr (FY 2025).
Selvaraju Pandurangan held 5 earlier board appointments: Park Hill Estates Private Limited (Director, 25 May 2012 to 09 May 2016); Pda Holdings Private Limited (Director, 28 Jan 2015 to 14 Dec 2015); Karaikudi Medical Centre And Hospital Limited (Director, 12 Feb 2020 to 31 Oct 2020); Mediplus Healthcare Pharmacy India Private Limited (Director, 20 Feb 2008 to 16 Apr 2018); Alliance Diagnostics Llp (Designated Partner, from 23 Mar 2020).
The current boards of Selvaraju Pandurangan's companies include Athmanathan Ganesan (Sri Kauvery Medical Care (India) Limited), Duraisamy Senguttuvan (Sri Kauvery Medical Care (India) Limited), Gomathy Babu Sadacharam Kulandaivelu (Sri Kauvery Medical Care (India) Limited), Kumaraswamy Anandababu (Sri Kauvery Medical Care (India) Limited), Manikandan Jeyabaskaran (Sri Kauvery Medical Care (India) Limited), Nandini Rangaswamy (Sri Kauvery Medical Care (India) Limited), among others.